Charles Eaton MD is a hand surgeon, founder, and executive Director of the Dupuytren Research Group. He has authored over 40 peer-reviewed academic publications and textbook chapters and is the editor of two Dupuytren textbooks. Dr. Eaton is the architect and principal investigator of the International Dupuytren Data Bank.
Do you see an issue with self-diagnosis? There is potential for a patient to self-diagnose incorrectly and may have some other disorder similar to Dupuytren (possibly an unknown autoimmune disorder). Do you worry that the population of self-diagnosed patients in your database who may have incorrectly self-diagnosed would skew analysis results?
Answered yesterday at 8:40pm
If you could model the “type” of disease that best fits for this crowd sourced approach, what would it be? For instance, this likely wouldn’t work for researching a rare disease, correct?
Answered yesterday at 8:10pm
The questions, answers and comments posted under this Expert Q&A forum reflect the views of the author(s) and should not be construed to represent views or policies held by the FDA. Experts answer questions at their discretion and thus not all questions may be addressed. The Expert Q&A forum is also not intended to address questions pertaining to medical advice, diagnosis or treatment.